Literature DB >> 19382266

HCV genotypes in Sicily: is there any evidence of a shift?

Paola Pizzillo1, Piero Luigi Almasio, Donatella Ferraro, Antonio Craxì, Rosa Di Stefano.   

Abstract

The distribution of HCV strains in any area is characterized by a relative prevalence of one genotype, and a number of less prevalent types. In some Western countries a change from the prevalent HCV genotype 1 to genotypes 3 and 4 has been reported in the last decade. In order to assess possible variations of the distribution of HCV genotypes in Sicily, a southern region of Italy, a hospital-based cohort, collected prospectively, of 3,209 subjects with chronic HCV infection was surveyed, comparing the distribution of HCV genotypes during two consecutive periods, from 1997 to 2002 and from 2003 to 2007, according to age and gender. The results show that genotype 1b, which has been historically the most prevalent in Sicily, is still predominant, followed more distantly by genotypes 2 and 3a. However, a cohort effect for these genotypes was seen when comparing the two time periods. Genotype 1b decreased slowly over the last decade, due to the death of the people infected, leading to a proportional increase of the other genotypes. No evidence was found in support of a major increase in the prevalence of other genotypes, such as genotype 4, in relation to migration patterns.

Entities:  

Mesh:

Year:  2009        PMID: 19382266     DOI: 10.1002/jmv.21498

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy.

Authors:  Umberto Restelli; Alfredo Alberti; Adriano Lazzarin; Marzia Bonfanti; Carmela Nappi; Davide Croce
Journal:  Eur J Health Econ       Date:  2016-12-22

2.  Eleven-year distribution pattern of hepatitis C virus in southern Italy.

Authors:  Nadia Marascio; Giovanni Matera; Angela Quirino; Aida Giancotti; Giorgio S Barreca; Angelo G Lamberti; Benedetto Caroleo; Maria Carla Liberto; Alfredo Focà
Journal:  J Pathog       Date:  2012-08-09

3.  Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition.

Authors:  Giuseppina Maria Elena Colomba; Noemi Urone; Vito di Marco; Donatella Ferraro
Journal:  Viruses       Date:  2020-11-28       Impact factor: 5.048

Review 4.  Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region.

Authors:  M C Liberto; N Marascio; E Zicca; G Matera
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

5.  Estimation of the number of HCV-positive patients in Italy.

Authors:  Ivan Gardini; Marco Bartoli; Massimiliano Conforti; Francesco Saverio Mennini; Andrea Marcellusi
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.